NO980171D0 - Anvendelse av 1,4-dihydropyridin-derivater ved forebyggelse av behandling av aterosklerotisk nedbrytning av arterie-vegger - Google Patents

Anvendelse av 1,4-dihydropyridin-derivater ved forebyggelse av behandling av aterosklerotisk nedbrytning av arterie-vegger

Info

Publication number
NO980171D0
NO980171D0 NO980171A NO980171A NO980171D0 NO 980171 D0 NO980171 D0 NO 980171D0 NO 980171 A NO980171 A NO 980171A NO 980171 A NO980171 A NO 980171A NO 980171 D0 NO980171 D0 NO 980171D0
Authority
NO
Norway
Prior art keywords
arterial walls
prevention
treatment
lercanidipine
atherosclerotic
Prior art date
Application number
NO980171A
Other languages
English (en)
Norwegian (no)
Other versions
NO980171L (no
Inventor
Abraham Sartani
Amedeo Leonardi
Rudolfo Testa
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of NO980171D0 publication Critical patent/NO980171D0/no
Publication of NO980171L publication Critical patent/NO980171L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO980171A 1995-07-14 1998-01-14 Anvendelse av 1,4-dihydropyridin-derivater ved forebyggelse av behandling av aterosklerotisk nedbrytning av arterie-vegger NO980171L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI951513A IT1275532B (it) 1995-07-14 1995-07-14 Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa
PCT/EP1996/002872 WO1997003669A1 (en) 1995-07-14 1996-06-28 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls

Publications (2)

Publication Number Publication Date
NO980171D0 true NO980171D0 (no) 1998-01-14
NO980171L NO980171L (no) 1998-01-14

Family

ID=11371972

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980171A NO980171L (no) 1995-07-14 1998-01-14 Anvendelse av 1,4-dihydropyridin-derivater ved forebyggelse av behandling av aterosklerotisk nedbrytning av arterie-vegger

Country Status (19)

Country Link
EP (1) EP0839036B1 (hu)
JP (1) JPH11509214A (hu)
KR (1) KR19990028741A (hu)
CN (1) CN1190345A (hu)
AT (1) ATE183644T1 (hu)
AU (1) AU690471B2 (hu)
CA (1) CA2219501A1 (hu)
CZ (1) CZ11698A3 (hu)
DE (1) DE69603968T2 (hu)
DK (1) DK0839036T3 (hu)
ES (1) ES2138359T3 (hu)
GR (1) GR3031096T3 (hu)
HU (1) HUP9802736A3 (hu)
IL (1) IL122302A (hu)
IT (1) IT1275532B (hu)
NO (1) NO980171L (hu)
SK (1) SK4198A3 (hu)
WO (1) WO1997003669A1 (hu)
ZA (1) ZA965924B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20011726A1 (it) * 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
US6852737B2 (en) 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
TW200613275A (en) * 2004-08-24 2006-05-01 Recordati Ireland Ltd Lercanidipine salts
AR053023A1 (es) * 2005-02-25 2007-04-18 Recordati Ireland Ltd Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen
WO2011161223A2 (en) 2010-06-23 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
MX2013004151A (es) 2010-10-12 2013-05-20 Medicines Co Formulaciones de emulsion de clevidipina que contienen agentes antimicrobianos.
SI2654729T1 (sl) 2010-12-24 2016-08-31 Krka, D.D., Novo Mesto Homogene farmacevtske oralne dozirne oblike, ki obsegajo lerkanidipin in enalapril ali njune farmacevtsko sprejemljive soli skupaj z organsko kislino

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters

Also Published As

Publication number Publication date
JPH11509214A (ja) 1999-08-17
ATE183644T1 (de) 1999-09-15
DE69603968D1 (de) 1999-09-30
IL122302A (en) 2000-08-13
ITMI951513A1 (it) 1997-01-14
IL122302A0 (en) 1998-04-05
KR19990028741A (ko) 1999-04-15
SK4198A3 (en) 1998-05-06
GR3031096T3 (en) 1999-12-31
ES2138359T3 (es) 2000-01-01
EP0839036A1 (en) 1998-05-06
CN1190345A (zh) 1998-08-12
CA2219501A1 (en) 1997-02-06
WO1997003669A1 (en) 1997-02-06
ITMI951513A0 (it) 1995-07-14
HUP9802736A3 (en) 2000-03-28
IT1275532B (it) 1997-08-07
NO980171L (no) 1998-01-14
ZA965924B (en) 1997-01-30
HUP9802736A2 (hu) 1999-03-29
DE69603968T2 (de) 2000-04-06
EP0839036B1 (en) 1999-08-25
CZ11698A3 (cs) 1998-06-17
DK0839036T3 (da) 2000-01-24
AU6516496A (en) 1997-02-18
AU690471B2 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
IS4536A (is) Ný taxóíð, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þau
AR017639A1 (es) Procedimiento de la alquilacion directa en una etapa, en las posiciones 7 y 10 simultaneamente de las dos funciones hidroxilos de la 10-desacetilbacatina o de los derivados de esta ultima esterificados en la posicion 13.
NO975985L (no) Aromatiske forbindelser og farmasöytiske blandinger inneholdende dem
CY2008012I1 (el) Υδροξυεστερες ραπαμυκινης, διαδικασια για τη παρασκευη τους και φαρμακευτικες συνθεσεις περιεχουσες αυτες
NO982311D0 (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral mukositt
NO970373D0 (no) Benzoksazoler og pyridinderivater anvendelige ved behandling av type-II-diabetes
DE69914854D1 (de) Sulfoxidderivate und Acetonkomplexe und Verfahren zu ihrer Herstellung
NO975984L (no) Aromatiske forbindelser og farmasöytiske blandinger inneholdende dem
IS4635A (is) 4-fenýlamínóþíasólafleiður, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær
FR2739860B1 (fr) Complexes amphiphiles, procede pour leur preparation et compositions en renfermant
ZA988016B (en) Compounds methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
NO980171D0 (no) Anvendelse av 1,4-dihydropyridin-derivater ved forebyggelse av behandling av aterosklerotisk nedbrytning av arterie-vegger
ATA900894A (de) Pharmazeutische kompositionen zum vorbeugen und heilen von krebserkrankungen und verfahren zu ihrer herstellung
IS4809A (is) Taxóíð, efnasmíði þeirra og lyfjasamsetning sem inniheldur þau
UA35566C2 (uk) Лікарський засіб для профілактики і лікування порушень ліпоїдного і холестеринового обміну речовин і спосіб профілактики і лікування цих порушень
FI953956A (fi) 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
TW372962B (en) Pharmaceutical compositions for the prevention, arrest or reversal of atherosclerotic degradation in the arterial walls of a patient
ATE140455T1 (de) Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
AU8058194A (en) A pharmaceutical composition for the treatment of coronary thrombosis
DE59200566D1 (de) Aryl-Chinolyl-substituierte 1,4-Dihydropyridin-dicarbonsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln.
NO953322D0 (no) Anvendelse av 1,4-dihydropyridin-3,5-dikarboksylsyreestere som legemidler
CA2239159A1 (en) Acylated enol derivatives of .alpha.-ketoesters and .alpha.-ketoamides
DE69419674D1 (de) Optisch aktive 1,4-Dihydropyridinderivate und Verfahren zu ihrer Herstellung
AU2899099A (en) Composition for treatment and prevention of coronary artery disease
AU7389496A (en) Methods and compositions for treating vascular stenosis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application